Lankes Heather A, Fought Angela J, Evens Andrew M, Weisenburger Dennis D, Chiu Brian C-H
Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, 680 North Lake Shore Drive, Suite 1102, Chicago, IL 60611-4402, USA.
Cancer Causes Control. 2009 Jul;20(5):517-23. doi: 10.1007/s10552-008-9259-x. Epub 2008 Nov 15.
As factors that alter the immune system have been implicated in non-Hodgkin lymphoma (NHL) etiology, it is of interest to explore the association between vaccination and risk of NHL. Results of few epidemiologic studies conducted thus far are inconsistent, and only one has examined the association by histologic subtype.
A population-based, case-control study of 387 patients with NHL and 535 controls conducted in Nebraska between 1999 and 2002.
Information on vaccination for tetanus, polio, influenza, smallpox, and tuberculosis, as well as important environmental factors, was collected by telephone interview. Risk was estimated by odds ratios (ORs) and 95% confidence intervals (CIs), adjusting for confounders.
We found that NHL risk was inversely associated with ever receiving a polio (OR = 0.59, CI = 0.40-0.87) or smallpox (OR = 0.71, CI = 0.51-0.98) vaccination, and positively associated with influenza vaccination (OR = 1.53, CI = 1.14-2.06). No significant association was found for tetanus or tuberculosis vaccination. The patterns of association were similar between men and women. Analysis by histologic subtypes showed that polio vaccination was associated with a lower risk of follicular (OR = 0.54, CI = 0.31-0.92) and chronic lymphocytic leukemia/small lymphocytic lymphomas (OR = 0.29, CI = 0.12-0.69) and smallpox vaccination was associated with a lower risk of marginal zone lymphoma (OR = 0.41, CI = 0.19-0.88). In contrast, ever receiving an influenza vaccination was associated with a higher risk of follicular (OR = 1.98, CI = 1.23-3.18) and diffuse large B cell lymphomas (OR = 1.88, CI = 1.13-3.12).
Risk of NHL is inversely associated with polio and smallpox vaccination and positively associated with influenza vaccination. These associations appear to differ by histologic subtype.
由于改变免疫系统的因素与非霍奇金淋巴瘤(NHL)的病因有关,因此探索疫苗接种与NHL风险之间的关联具有重要意义。迄今为止进行的少数流行病学研究结果并不一致,且仅有一项研究按组织学亚型考察了这种关联。
1999年至2002年在 Nebraska 开展的一项基于人群的病例对照研究,纳入387例NHL患者和535例对照。
通过电话访谈收集破伤风、脊髓灰质炎、流感、天花和结核病疫苗接种信息以及重要环境因素信息。通过比值比(OR)和95%置信区间(CI)估计风险,并对混杂因素进行校正。
我们发现,NHL风险与曾接种脊髓灰质炎疫苗(OR = 0.59,CI = 0.40 - 0.87)或天花疫苗(OR = 0.71,CI = 0.51 - 0.98)呈负相关,与流感疫苗接种呈正相关(OR = 1.53,CI = 1.14 - 2.06)。未发现破伤风或结核病疫苗接种与NHL风险存在显著关联。男性和女性的关联模式相似。按组织学亚型分析显示,脊髓灰质炎疫苗接种与滤泡性淋巴瘤(OR = 0.54,CI = 0.31 - 0.92)和慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(OR = 0.29,CI = 0.12 - 0.69)风险较低相关,天花疫苗接种与边缘区淋巴瘤风险较低相关(OR = 0.41,CI = 0.19 - 0.88)。相反,曾接种流感疫苗与滤泡性淋巴瘤(OR = 1.98,CI = 1.23 - 3.18)和弥漫性大B细胞淋巴瘤(OR = 1.88,CI = 1.13 - 3.12)风险较高相关。
NHL风险与脊髓灰质炎和天花疫苗接种呈负相关,与流感疫苗接种呈正相关。这些关联在不同组织学亚型中似乎有所不同。